Peker, E., Erdogan, A
Description How It Works GHK-Cu is studied for its involvement in several essential regenerative pathways
Results showed that glutathione supplementation was again associated with suppression in lactate levels, while fatigue measures were also significantly decreased, compared to the placebo group
Arsova-Sarafinovska Z, Matevska N, Eken A, Petrovski D, Banev S, Dzikova S, Georgiev V, Sikole A, Erdem O, Sayal A, et al
It doesn't target weight
Final research-target dose 2.4 mg + 2.4 mg weekly Titration length ~16 weeks Trial duration 68 weeks (REDEFINE 1 / REDEFINE 2) Route Subcutaneous, once weekly Compound Delivery: 2.4 mg / 2.4 mg Maintenance Pre-blended vials simplify weekly administration to a single injection but lock the ratio at 1:1